Skip to main content
. 2020 Apr 2;106(3):701–707. doi: 10.3324/haematol.2019.242677

Figure 1.

Figure 1.

Profile and frequency of mutations in the two study groups. (A) Profile of mutations according to the suspected context in diagnosis group A. Red: somatic mutations; blue: variant of undetermined significance (VUS); gray: not evaluated. (B) Profile of mutations according to the proven pathology in prognosis group B. Red: somatic mutations; blue: VUS, gray: not evaluated. ICUS: idiopathic cytopenia of undetermined significance without dysplasia; MDS: myelodysplastic syndrome; MPN: myeloproliferative neoplasm; AA: aplastic anemia; hMDS: hypoplastic myelodysplasia.